CELL BIOTECH CO ., LTD Logo

CELL BIOTECH CO ., LTD

A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.

049960 | KO

Overview

Corporate Details

ISIN(s):
KR7049960008
LEI:
Country:
South Korea
Address:
경기 김포시 월곶면 개곡리 134, 김포시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cell Biotech Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and marketing of innovative probiotic solutions. Leveraging over 30 years of experience and proprietary fermentation and coating technologies, the company produces high-quality lactic acid bacteria (LAB) and GRAS-safe strains. Its core business includes producing probiotic raw materials, marketed as LAB2PRO; offering comprehensive OEM/ODM services for finished products tailored to global clients; and managing its own consumer brand, DUOLAC, which is exported to approximately 40 countries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-07 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2025-07-25 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.5 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 893.4 KB
2025-05-09 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 29.3 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.7 KB
2025-03-19 00:00
Audit Report / Information
[첨부추가]사업보고서 (2024.12)
Korean 438.4 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 112.4 KB
2025-03-13 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 107.7 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 108.1 KB

Automate Your Workflow. Get a real-time feed of all CELL BIOTECH CO ., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CELL BIOTECH CO ., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CELL BIOTECH CO ., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Lexaria Bioscience Corp. Logo
Biotech firm with patented technology improving oral drug delivery and absorption.
United States of America
LEXX
Lexeo Therapeutics, Inc. Logo
Develops AAV gene therapies for genetic cardiovascular and Alzheimer's diseases.
United States of America
LXEO
LEXICON PHARMACEUTICALS, INC. Logo
Develops gene-based drugs for chronic diseases, including treatments for heart failure.
United States of America
LXRX
LIFECORE BIOMEDICAL, INC. \DE\ Logo
A CDMO for parenteral drugs, producing injectable-grade sodium hyaluronate (HA).
United States of America
LFCR
Liminatus Pharma, Inc. Logo
Clinical-stage immuno-oncology firm developing cancer therapies targeting the CD47 checkpoint.
United States of America
LIMN
Lineage Cell Therapeutics Inc. Logo
Developing off-the-shelf cell therapies for neurological and ophthalmic conditions.
Israel
LCTX
Lipigon Pharmaceuticals AB Logo
Develops novel drugs for lipid metabolism disorders to reduce cardiovascular disease risk.
Sweden
LPGO
Lipocine Inc. Logo
Biopharma developing oral drugs for metabolic & endocrine disorders using delivery technology.
United States of America
LPCN
Lipum AB Logo
Develops first-in-class antibody treatments for chronic inflammatory diseases like arthritis.
Sweden
LIPUM
Liquidia Corp Logo
Develops inhaled therapies for rare cardiopulmonary diseases using proprietary PRINT® technology.
United States of America
LQDA

Talk to a Data Expert

Have a question? We'll get back to you promptly.